Quality of Life in Lung Cancer Survivors
This trial is active, not recruiting.
|Condition||lung cancer survivors|
|Treatment||questionnaires or telephone interview|
|Sponsor||Memorial Sloan Kettering Cancer Center|
|Collaborator||Fox Chase Cancer Center|
|Start date||June 2005|
|End date||June 2017|
|Trial size||193 participants|
|Trial identifier||NCT00586937, 05-057|
The purpose of this study is to find out about the quality of life of individuals who have been diagnosed and treated for lung cancer (lung cancer survivors). By quality of life, we mean how you are feeling about different aspects of your life, including your physical health, your emotional health, and your ability to carry out daily activities. We are interested in people's opinions about their quality of life, as well as the factors that affect their quality of life. Learning about quality of life will help us to develop new services for lung cancer survivors.
To describe the health-related quality of life (HQOL) of lung cancer survivors and compare their HQOL with age- and gender-appropriate, population-based normative data.
time frame: 2 years
To describe and identify covariates of HQOL in lung cancer survivors.
time frame: 2 years
Male or female participants of any age.
Inclusion Criteria: - Diagnosis of primary Stage IA or IB NSCLC; - Underwent surgical resection for NSCLC at MSKCC; - From 1 to 5 years and 11 months post-treatment for NSCLC prior to study recruitment; - No evidence of disease (NED) at the time of recruitment; - Can be reached by telephone; - Able to provide informed consent. Exclusion Criteria: - Undergoing active antineoplastic treatment; - Major psychopathology or cognitive impairment likely in the judgment of the investigator to interfere with participation and compliance with the protocol.
|Official title||Quality of Life in Lung Cancer Survivors|
|Principal investigator||Jamie Ostroff, PhD|
Call for more information